Dr. Robert Vries

Chief Executive Officer

Robert received his PhD in Biochemistry from the Leiden University Medical Center on the study of Oncogenic cell transformation. He subsequently moved to Stanford University (USA) to do his Post Doc studying neural stem cells. Upon his return to the Netherlands he continued the study of stem cells in the group of Prof. Hans Clevers at the Hubrecht Institute in The Netherlands.

 

In the group of Hans Clevers he was part of the team that developed the breakthrough technology that allowed the expansion of adult stem cells. The so called Organoid Technology became the basis of ‘Hubrecht Organoid Technology’ (HUB) of which he is currently the CEO.

January 19, 2021 SLAS 2021 Educational Track: Automation Technologies This track focuses on the innovative use of biological or chemistry applicati... read more
September 04, 2020 HUB and BGI-Qingdao sign a Memorandum of Unde... Utrecht and Qingdao, Sep 4th, 2020 – Hubrecht Organoid Technology (HUB) and BGI-Qingdao announced today that they ... read more
May 27, 2020 Studying the development of ovarian cancer wi... read more